NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/18/2025
Back to search
Official data from USPTO
ENDO USA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENDO USA
ST13
US500000098516417Class
5, 10, 35, 40, 41, 42, 44
Filing
98516417
Registration
8027143
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10, 35, 40, 41, 42, 44
Filing date
04/24/2024
Registration date
11/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/18/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Ballsbridge Dublin 4, IE
Examiner
GILLANI, MAHREEN A
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Endo Operations Limited
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5Class 10Class 35Class 40Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations in connection with critical carecritical testingmaternal healthanesthesiamalignant diseaseskidney disorderscelluliteskin caredermatological usefoldsscarsbody contouring and for rejuvenating the skinready to-administer injectable pharmaceutical preparations for the treatment of allergic reactionshypotensionshockmalignant diseaseskidney disordersto provide and reverse muscle relaxation to be used in patient care facilitieshospitalsacute care facilitieslong term care facilities and in doctor's offices; pharmaceutical preparationsanalgesics and pain management preparationspreparations for the treatment of cancerspreparations for the treatment of urological diseases and disorderspreparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine systemhormone replacement therapy preparations; drug substancesenzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels for dermatological use and mineral supplements; food supplements; radio frequency identification tagged pharmaceutical productssympathomimetic agentsdiagnostic agentsanticoagulantsthrombin inhibitorsanestheticsanalgesicsendocrine metabolicsantibacterial agentsantibioticsskeletal muscle relaxantsinjectable estrogensantifungalsimmunosuppressive agentsparasympathomimetic agentsvasoconstrictorsoxytocic agentsantiemeticsvasopressin antagonistsvasodilatorsvasopressorsanti-epilepticsanticonvulsantscholinesterase inhibitorsantimuscarinic agents; pharmaceutical preparations for endocrinologyorthopedicsurologysympathomimetic agentsdiagnostic agentsanticoagulantsthrombin inhibitorsanestheticsanalgesicsendocrine metabolicsantibacterial agentsantibioticsskeletal muscle relaxantsinjectable estrogensantifungalsimmunosuppressive agentsparasympathomimetic agentsvasoconstrictorsoxytocic agentsantiemeticsvasopressin antagonistsvasodilatorsvasopressorsanti-epilepticsanticonvulsantscholinesterase inhibitorsantimuscarinic agents
Class 10
Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devicessurgical equipment in the fields of urology and men's health; Medical devicesintrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine; medical devices for use in treating critical carecritical testingmaternal healthanesthesiadiseaseskidney disorderscelluliteskin caredermatological usefoldsscarsbody contouringarterial lineblood glucose metersmedical x-ray apparatuselectrocardiographic (ECG) recordersMedical apparatus and instruments for treating cardiovascular diseasemedical instruments to measure blood pressurecardiac output and other physiological and cardiovascular parameterscontinuous renal replacement therapy devices (CRRT)dialyzersblood filtersfilters for anesthesiasubcision devices for treating celluliteLED light therapy devices for skin care and dermatologicial usevocal fold medializations devices for folderssilicone gel sheeting for the treatment of scarslasers for medical purposeslasers for skin treatmentultrasound apparatus for body contouringradiofrequency therapy apparatus for cellulite reduction and body slimming
Class 35
Healthcare management servicesproviding administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
Class 40
Custom manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
Class 41
Educational servicesconducting classesseminarsworkshops in the field of pharmaceutical preparationsmedical devices and techniques; Educational servicesconducting classesseminarsworkshops and training for doctorsnurses and others in the fields of critical carecritical testingmaternal healthrare diseases and conditionsanesthesiaaesthetic solutions to help patients feel better about their bodies
Class 42
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others; Research and development of pharmaceutical products for others
Class 44
Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicinesmedical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling informationadvice and data on the subjects of pharmaceutical preparations and medicine; Providing medical information on the subjects of aesthetic solutions to help patients feel better about their bodies; Patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/30/2025
PUBO
PUBLISHED FOR OPPOSITION
09/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/24/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2025
GNRT
NON-FINAL ACTION E-MAILED
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
08/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2025
ALIE
ASSIGNED TO LIE
05/06/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/24/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/15/2025
GNSL
LETTER OF SUSPENSION E-MAILED
01/15/2025
CNSL
SUSPENSION LETTER WRITTEN
01/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/10/2024
GNRT
NON-FINAL ACTION E-MAILED
11/10/2024
CNRT
NON-FINAL ACTION WRITTEN
11/10/2024
DOCK
ASSIGNED TO EXAMINER
10/31/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2024
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
07/26/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/26/2024
NWAP
NEW APPLICATION ENTERED
04/24/2024
Continuous trademark protection
Get notified about every new filing that threatens ENDO USA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.